Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00056836
What this trial is testing

Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

Who this might be right for
Macular Degeneration
Genentech, Inc. 720
Early research (Phase 1)Study completedNCT05953012
What this trial is testing

Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
PharmAbcine 17
Testing effectiveness (Phase 2)Looking for participantsNCT06458595
What this trial is testing

Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 44
Not applicableStudy completedNCT06723288
What this trial is testing

A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche 736
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT02181517
What this trial is testing

Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Large-scale testing (Phase 3)Looking for participantsNCT07614776
What this trial is testing

Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular DegenerationnAMD
Amgen 304
Early research (Phase 1)Study completedNCT02332941
What this trial is testing

Treatment -Resistant Neovascular Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
Washington University School of Medicine 5
Not applicableUnknownNCT05342857
What this trial is testing

Maximum Treatment Interval With Aflibercept T&E

Who this might be right for
Neovascular Age-related Macular Degeneration
Shin Kong Wu Ho-Su Memorial Hospital 100
Not applicableStudy completedNCT06124677
What this trial is testing

Single Injection of Faricimab for nAMD With Persisting Fluid Despite Frequent Aflibercept Treatments

Who this might be right for
Neovascular Age-related Macular Degeneration
Rigshospitalet, Denmark 46
Testing effectiveness (Phase 2)UnknownNCT06487039
What this trial is testing

Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
EyebioKorea, Inc. 50
Early research (Phase 1)Study completedNCT05643118
What this trial is testing

Evaluation of OLX10212 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Olix Pharmaceuticals, Inc. 21
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Post-approval studies (Phase 4)Ended earlyNCT00312351
What this trial is testing

A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals 262
Testing effectiveness (Phase 2)Study completedNCT01926977
What this trial is testing

Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Arshad Khanani 100
Large-scale testing (Phase 3)Study completedNCT00637377
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Bayer 1,240
Large-scale testing (Phase 3)Study completedNCT01835067
What this trial is testing

Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

Who this might be right for
Exudative Macular DegenerationRetinal Hemorrhage
King's College Hospital NHS Trust 55
Not applicableLooking for participantsNCT06929507
What this trial is testing

Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

Who this might be right for
Renal Function DisorderDiabetic Macular Edema (DME)Neovascular Age Related Macular Degeneration
University Hospital, Alexandroupolis 60
Early research (Phase 1)Active Not RecruitingNCT06817343
What this trial is testing

A Long-term Follow up Study of EXG102-031 in Patients With wAMD (Everest LTFU)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Neovascular (Wet) Age-related Macular Degeneration (AMD)
Exegenesis Bio 12
Large-scale testing (Phase 3)Study completedNCT03954626
What this trial is testing

Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD

Who this might be right for
Age-Related Macular DegenerationMacular DegenerationWet Macular Degeneration+3 more
Novartis Pharmaceuticals 14
Next Page